ECO HUM VE Verus FDA Adivsors LLC How Regulatory Strategy Impacts Valuation in MedTech and Health Products For founders and investors in the healthcare sector, valuation is often driven by technology, market size, and revenue potential. However…
AI VE Verus FDA Adivsors LLC Navigating the 2026 AI Regulatory Landscape: Top 3 Reasons the FDA Rejects SaMD 510(k)s In 2026, the gold rush for AI-enabled Software as a Medical Device (SaMD) has reached a fever pitch. With the FDA clearing hundreds of new…
